Literature DB >> 21741761

The epidemiology of renal cell carcinoma.

Börje Ljungberg1, Steven C Campbell, Han Yong Choi, Han Yong Cho, Didier Jacqmin, Jung Eun Lee, Steffen Weikert, Lambertus A Kiemeney.   

Abstract

CONTEXT: Kidney cancer is among the 10 most frequently occurring cancers in Western communities. Globally, about 270 000 cases of kidney cancer are diagnosed yearly and 116 000 people die from the disease. Approximately 90% of all kidney cancers are renal cell carcinomas (RCC).
OBJECTIVE: The causes of RCC are not completely known. We have reviewed known aetiologic factors. EVIDENCE ACQUISITION: The data provided in the current review are based on a thorough review of available original and review articles on RCC epidemiology with a systemic literature search using Medline. EVIDENCE SYNTHESIS: Smoking, overweight and obesity, and germline mutations in specific genes are established risk factors for RCC. Hypertension and advanced kidney disease, which makes dialysis necessary, also increase RCC risk. Specific dietary habits and occupational exposure to specific carcinogens are suspected risk factors, but results in the literature are inconclusive. Alcohol consumption seems to have a protective effect for reasons yet unknown. Hardly any information is available for some factors that may have a high a priori role in the causation of RCC, such as salt consumption.
CONCLUSIONS: Large collaborative studies with uniform data collection seem to be necessary to elucidate a complete list of established risk factors of RCC. This is necessary to make successful prevention possible for a disease that is diagnosed frequently in a stage where curative treatment is not possible anymore.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2011        PMID: 21741761     DOI: 10.1016/j.eururo.2011.06.049

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  353 in total

1.  [Partial nephrectomy. Rationale and limitations of an organ-preserving approach].

Authors:  J Casuscelli; C Gratzke; C G Stief; M Staehler
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

Review 2.  Prognostic value of cytoreductive nephrectomy combined with targeted therapy for metastatic renal cell carcinoma: a meta-analysis.

Authors:  Xuwei Hong; Fei Li; Kaiqiang Tang; Shiyu Pang; Guangzheng Lin; Shi Li; Jiming Bao; Wanlong Tan
Journal:  Int Urol Nephrol       Date:  2016-02-09       Impact factor: 2.370

Review 3.  Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).

Authors:  Juan I Martínez-Salamanca; Estefania Linares; Javier González; Roberto Bertini; Joaquín A Carballido; Thomas Chromecki; Gaetano Ciancio; Sia Daneshmand; Christopher P Evans; Paolo Gontero; Axel Haferkamp; Markus Hohenfellner; William C Huang; Theresa M Koppie; Viraj A Master; Rayan Matloob; James M McKiernan; Carrie M Mlynarczyk; Francesco Montorsi; Hao G Nguyen; Giacomo Novara; Sascha Pahernik; Juan Palou; Raj S Pruthi; Krishna Ramaswamy; Oscar Rodriguez Faba; Paul Russo; Shahrokh F Shariat; Martin Spahn; Carlo Terrone; Derya Tilki; Daniel Vergho; Eric M Wallen; Evanguelos Xylinas; Richard Zigeuner; John A Libertino
Journal:  Curr Urol Rep       Date:  2014-05       Impact factor: 3.092

4.  Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes.

Authors:  Emmanuel I Papadopoulos; George M Yousef; Andreas Scorilas
Journal:  Tumour Biol       Date:  2015-04-02

5.  Contemporary assessment of the correlation between Bosniak classification and histological characteristics of surgically removed atypical renal cysts (UroCCR-12 study).

Authors:  François-Xavier Nouhaud; Jean-Christophe Bernhard; Pierre Bigot; Zine-Eddine Khene; François Audenet; Herve Lang; Sebastien Bergerat; Guillaume Fraisse; Nicolas Grenier; François Cornelis; Cosmina Nedelcu; Sofiane Béjar; Gaëlle Fromont-Hankard; Yves Allory; Véronique Lindner; Virginie Verkarre; Laurent Daniel; Mokrane Yacoub; Jean-Michel Correas; Arnaud Méjean; Nathalie Rioux-Leclercq; Karim Bensalah
Journal:  World J Urol       Date:  2018-05-05       Impact factor: 4.226

Review 6.  A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy.

Authors:  Tobias Klatte; Vincenzo Ficarra; Christian Gratzke; Jihad Kaouk; Alexander Kutikov; Veronica Macchi; Alexandre Mottrie; Francesco Porpiglia; James Porter; Craig G Rogers; Paul Russo; R Houston Thompson; Robert G Uzzo; Christopher G Wood; Inderbir S Gill
Journal:  Eur Urol       Date:  2015-04-22       Impact factor: 20.096

7.  Induction of cell cycle arrest, DNA damage, and apoptosis by nimbolide in human renal cell carcinoma cells.

Authors:  Yi-Hsien Hsieh; Chien-Hsing Lee; Hsiao-Yun Chen; Shu-Ching Hsieh; Chia-Liang Lin; Jen-Pi Tsai
Journal:  Tumour Biol       Date:  2015-04-28

8.  Overexpression of cannabinoid receptor 1 promotes renal cell carcinoma progression.

Authors:  Jianfeng Wang; Yunze Xu; Yun Zou; Liangsong Zhu; Baijun Dong; Jiwei Huang; Yonghui Chen; Wei Xue; Yiran Huang; Wen Kong; Jin Zhang
Journal:  Tumour Biol       Date:  2016-10-18

Review 9.  Pazopanib: a review of its use in the management of advanced renal cell carcinoma.

Authors:  Paul L McCormack
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

10.  DNA repair system and renal cell carcinoma prognosis: under the influence of NBS1.

Authors:  Alina Rosinha; Joana Assis; Francisca Dias; Augusto Nogueira; Deolinda Pereira; Joaquina Maurício; Ana Luísa Teixeira; Rui Medeiros
Journal:  Med Oncol       Date:  2015-10-22       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.